Startup founder Charlie Javice found guilty of defrauding JPMorgan Chase in $175 million deal

Startup founder Charlie Javice found guilty of defrauding JPMorgan Chase in 5 million deal


Charlie Javice, who is charged with defrauding JPMorgan Chase & Co into buying her now-shuttered college financial aid startup Frank for $175 million in 2021, arrives at United States Court in Manhattan in New York City, June 6, 2023.

Mike Segar | Reuters

Charlie Javice, founder of a startup purchased by JPMorgan Chase in 2021, was convicted in federal court Friday of defrauding the bank by vastly overstating the company’s customer list.

The jury decision comes after weeks of testimony in New York over who was to blame for the flameout of a once-promising startup. Frank, founded by Javice in 2016, aimed to help users apply for college financial aid.

JPMorgan has accused Javice, 32, of duping the bank into paying $175 million for a company that had more than 4 million customers, when in reality it had fewer than 300,000.

The largest U.S. bank by assets sued Javice in late 2022 after attempting to send marketing emails to some of the thousands of “customers” it thought Frank had. In its suit, JPMorgan released emails in which Javice hired a data scientist to generate a fake roster of customers.

Then, in April 2023, the Justice Department charged Javice with four crimes including wire and bank fraud, counts which carried lengthy maximum sentences. Javice was arrested at Newark airport on April 3 of that year and had been out on bail.

Sentencing will happen at a later date, per news reports.

A spokesperson for JPMorgan declined to comment.

This story is developing. Please check back for updates.



Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More